Intern - Development - Medical Affairs at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Must be at least 18 years old
Must have a minimum GPA of 2.8
Authorized to work in the United States without sponsorship now or in the future or CPT/OPT through your University
Must be currently enrolled as a full-time student in a Masters/MBA/PhD program at an accredited US based university or college
Must be a Rising Sophomore, Junior, or Senior in undergrad or a Graduate or Doctoral Student
Must be enrolled full-time in the Fall Semester at an accredited university/college after the completion of the internship

Responsibilities

Support Global Medical Affairs team in collaboration with commercial, R&D, medical communications, project management, and affiliate countries in multiple areas including advisory board planning, speaker education programs, conference preparation, publication planning, evidence generation planning, and abstracts/manuscripts/conference presentations reviewing
Assist in the development of global scientific messages, strategic documents, and additional medical content slide decks
Work collaboratively in creating and reviewing new and updated medical materials by Global Medical Affairs to ensure scientific balance and accuracy
Contribute with Global Medical Affairs teams to create and implement strategic tactical Global Medical Training
Assist with the development and execution of projects that will provide more extensive background, additional data/answers to questions in response to issues related to commercial, scientific, or data needs
Support Global Medical Affairs leadership on early development of a variety of projects as new business needs arise
Manage projects related to the review, approval, and medical oversight of Oncology Medical Affairs investigator sponsored research program
Manage expense budget related to Global Medical Affairs activities by tracking, preparing, and contributing to the budget and its estimates
Assist projects to completion, anticipating obstacles and difficulties that may arise and resolving them in a collaborative manner
Support oncology therapeutic areas by tracking and following-up activities/milestones through various project management tools
Offer innovative solutions and provide actionable insights
Showcase your work with a final presentation (PPT) near the conclusion of your internship

Skills

Medical Affairs

Advisory Board Planning

Speaker Education

Conference Preparation

Publication Planning

Evidence Generation

Project Management

Medical Communications

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free